Skip to main content

Zivo Bioscience, Inc. (ZIVO)

Sector
Healthcare
Industry
Biotechnology
Last price
$8.12
As of

Kresmion compiles this page from ZIVO's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Zivo Bioscience, Inc. (ZIVO): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-03-30.

As of . Source: SEC EDGAR filings for ZIVO. Method and limitations.

COMPANY DOSSIER

See the full ZIVO dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for ZIVO on one page. Preview it with sample data, then open it live with a free account.

Preview the ZIVO dossier

Active events for ZIVO

  • mediumEarnings below estimates

    Q3-2024: Missed consensus by 68.4% - EPS $-0.67 vs $-0.3978 estimate

  • mediumEarnings above estimates

    Q4-2024: Beat consensus by 37.0% - EPS $-0.36 vs $-0.5712 estimate

  • mediumEarnings below estimates

    Q1-2025: Missed consensus by 111.2% - EPS $-1.12 vs $-0.5304 estimate

FREE, NO ACCOUNT

Every event on ZIVO, as it fires

New filings, 13F moves and cross asset events on ZIVO land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter.

Recent SEC filings, ZIVO

Going concern statement

ZIVO's 10-Q filed Nov 14, 2025 states:

These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the financial statements are issued.

Read the 10-Q on SEC EDGAR Every company with a going concern statement

More data on ZIVO

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in ZIVO on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on ZIVO in the last 180 days.

Upstream: SEC EDGAR filings for ZIVO

Kresmion, "Zivo Bioscience, Inc. (ZIVO) institutional holdings and SEC filings", data as of 2026-05-31, https://kresmion.com/research/ZIVO. Upstream data: SEC EDGAR filings for ZIVO.

Link to this data (HTML):

<a href="https://kresmion.com/research/ZIVO">Zivo Bioscience, Inc. (ZIVO) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow ZIVO on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to ZIVO for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the ZIVO dossier
Share

The ZIVO intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.